Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benedikt Hoeh

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Frontiers in Surgery|August 26, 2021
Management of Medium and Long Term Complications Following Prostate Cancer Treatment Resulting in Urinary Diversion - A Narrative ReviewBenedikt Hoeh, Stefan C Müller, Luis A Kluth, et al.
Urologie (Heidelberg, Germany)|February 10, 2023
[Androgen deprivation therapy plus chemotherapy ± androgen receptor-targeting agents for metastatic hormone-sensitive prostate cancer]Mike Wenzel, Benedikt Hoeh, Felix K H Chun, et al.
International Journal of Computer Assisted Radiology and Surgery|May 9, 2025
An augmented reality overlay for navigated prostatectomy using fiducial-free 2D-3D registrationJohannes Bender, Jeremy Kwe, Benedikt Hoeh, et al.
International Urology and Nephrology|July 11, 2025
Adherence to post-therapeutic multidisciplinary tumor board recommendation and its influence on oncological outcomes in high-risk prostate cancer patients following radical prostatectomyBenedikt Hoeh, Jeremy Kwe, Fabian Schreiber, et al.
Urologie (Heidelberg, Germany)|December 21, 2023
[First clinical and oncological experiences with triplet therapy for high-volume metastatic hormone-sensitive prostate cancer]Mike Wenzel, Benedikt Hoeh, Jan Kasparek, et al.
BJUI Compass|July 9, 2026
Procedure efficiency and diagnostic outcomes during the learning curve of transperineal MRI-guided prostate biopsyMario Hallaschek, Jeremy Kwe, Friedrich Helke, et al.
European Urology Focus|September 4, 2022
Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysisPhilipp Mandel, Benedikt Hoeh, Mike Wenzel, et al.
European Urology Open Science|June 17, 2025
Ultralow Prostate-specific Antigen Nadir After Apalutamide: Outcomes in Synchronous Versus Metachronous Metastatic Hormone-sensitive Prostate CancerMike Wenzel, Thomas Steuber, Carolin Siech, et al.
Medicina (Kaunas, Lithuania)|January 23, 2024
Cardiovascular Disease and Chronic Pulmonary Disease Increase the Risk of Short-Term Major Postoperative Complications after Robotic-Assisted Radical ProstatectomyCarolin Siech, Antonia Gruber, Mike Wenzel, et al.
Urologic Oncology|September 27, 2023
Patient and tumor characteristics of histological subtypes of renal cell carcinoma and its risk of upstaging to ≥pT3Mike Wenzel, Benedikt Hoeh, Cristina Cano Garcia, et al.
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Frontiers in Surgery|August 26, 2021
Management of Medium and Long Term Complications Following Prostate Cancer Treatment Resulting in Urinary Diversion - A Narrative ReviewBenedikt Hoeh, Stefan C Müller, Luis A Kluth, et al.
Urologie (Heidelberg, Germany)|February 10, 2023
[Androgen deprivation therapy plus chemotherapy ± androgen receptor-targeting agents for metastatic hormone-sensitive prostate cancer]Mike Wenzel, Benedikt Hoeh, Felix K H Chun, et al.
International Journal of Computer Assisted Radiology and Surgery|May 9, 2025
An augmented reality overlay for navigated prostatectomy using fiducial-free 2D-3D registrationJohannes Bender, Jeremy Kwe, Benedikt Hoeh, et al.
International Urology and Nephrology|July 11, 2025
Adherence to post-therapeutic multidisciplinary tumor board recommendation and its influence on oncological outcomes in high-risk prostate cancer patients following radical prostatectomyBenedikt Hoeh, Jeremy Kwe, Fabian Schreiber, et al.
Urologie (Heidelberg, Germany)|December 21, 2023
[First clinical and oncological experiences with triplet therapy for high-volume metastatic hormone-sensitive prostate cancer]Mike Wenzel, Benedikt Hoeh, Jan Kasparek, et al.
BJUI Compass|July 9, 2026
Procedure efficiency and diagnostic outcomes during the learning curve of transperineal MRI-guided prostate biopsyMario Hallaschek, Jeremy Kwe, Friedrich Helke, et al.
European Urology Focus|September 4, 2022
Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysisPhilipp Mandel, Benedikt Hoeh, Mike Wenzel, et al.
European Urology Open Science|June 17, 2025
Ultralow Prostate-specific Antigen Nadir After Apalutamide: Outcomes in Synchronous Versus Metachronous Metastatic Hormone-sensitive Prostate CancerMike Wenzel, Thomas Steuber, Carolin Siech, et al.
Medicina (Kaunas, Lithuania)|January 23, 2024
Cardiovascular Disease and Chronic Pulmonary Disease Increase the Risk of Short-Term Major Postoperative Complications after Robotic-Assisted Radical ProstatectomyCarolin Siech, Antonia Gruber, Mike Wenzel, et al.
Urologic Oncology|September 27, 2023
Patient and tumor characteristics of histological subtypes of renal cell carcinoma and its risk of upstaging to ≥pT3Mike Wenzel, Benedikt Hoeh, Cristina Cano Garcia, et al.
Pageof 13